Effect of infliximab on sight-threatening panuveitis in Behcet's disease-Reference-Cited by-同舟云学术

Effect of infliximab on sight-threatening panuveitis in Behcet's disease

Published:2001-07 Issue:9278 Volume:358 Page:295-296
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sfikakis PP,Theodossiadis PG,Katsiari CG,Kaklamanis P,Markomichelakis NN

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Treatment of Behcet's disease: an update;Kaklamani;Semin Arthritis Rheum,2001

2. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease: soluble TNFR-75 as a biological marker of disease activity;Turan;J Rheumatol,1997

3. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases;Illei;Curr Opin Immunol,2000

4. Remission of Behcet's syndrome with tumour necrosis factor alpha blocking therapy;Goossens;Ann Rheum Dis,2001

5. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report;Hassard;Gastroenterology,2001

Cited by 425 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds;Biomedicine & Pharmacotherapy;2024-09

2. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond;Frontiers in Ophthalmology;2024-08-02

3. Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances;Journal of Neuroinflammation;2024-05-22

4. Behçet's syndrome;The Lancet;2024-03

5. Neurological involvement by Behçet’s syndrome: clinical features, diagnosis, treatment and outcome;Practical Neurology;2023-09-29